Clinical trial
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
NCT06041451 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early and Late Prognosis in Patients With Guillain-Barre Syndrome
- Lead sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 2, 2013
- Completion date
- January 31, 2025
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.